In a clinical trial with 61 MDD with high inflammation, only the 2 g/d dose of EPA decreased peripheral blood mononuclear cell tumor necrosis factor alpha (TNFα) levels, and EPA 4 g/d had a medium effect size for response rates compared to placebo. This evidence concerns the gene TNF and major depressive disorder.